ARL14
Basic information
Region (hg38): 3:160677160-160678448
Previous symbols: [ "ARF7" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARL14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 2 | 0 |
Variants in ARL14
This is a list of pathogenic ClinVar variants found in the ARL14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-160677354-C-T | not specified | Likely benign (Oct 12, 2021) | ||
3-160677399-T-G | not specified | Uncertain significance (Dec 04, 2023) | ||
3-160677471-T-A | not specified | Uncertain significance (Dec 14, 2021) | ||
3-160677477-C-T | not specified | Uncertain significance (May 05, 2023) | ||
3-160677487-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
3-160677503-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
3-160677514-G-C | not specified | Uncertain significance (Sep 21, 2023) | ||
3-160677683-A-G | not specified | Uncertain significance (Jul 11, 2023) | ||
3-160677728-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
3-160677741-C-T | not specified | Uncertain significance (Jan 04, 2022) | ||
3-160677756-C-G | not specified | Uncertain significance (Mar 20, 2023) | ||
3-160677779-C-A | not specified | Uncertain significance (Sep 12, 2023) | ||
3-160677791-C-G | not specified | Uncertain significance (Apr 09, 2024) | ||
3-160677791-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
3-160677828-G-A | not specified | Uncertain significance (May 30, 2022) | ||
3-160677830-G-A | not specified | Uncertain significance (May 25, 2022) | ||
3-160677846-G-T | not specified | Uncertain significance (Jun 06, 2023) | ||
3-160677877-C-T | Likely benign (Sep 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARL14 | protein_coding | protein_coding | ENST00000320767 | 1 | 1286 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000124 | 0.117 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.11 | 132 | 101 | 1.31 | 0.00000488 | 1255 |
Missense in Polyphen | 51 | 39.34 | 1.2964 | 501 | ||
Synonymous | 0.127 | 39 | 40.0 | 0.974 | 0.00000214 | 373 |
Loss of Function | -0.678 | 8 | 6.18 | 1.29 | 3.46e-7 | 70 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase that recruits MYO1E to MHC class II-containing vesicles via the effector protein ARL14EP and hence controls the movement of these vesicles along the actin cytoskeleton in dendritic cells. {ECO:0000269|PubMed:21458045}.;
Recessive Scores
- pRec
- 0.0898
Intolerance Scores
- loftool
- 0.695
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.23
Haploinsufficiency Scores
- pHI
- 0.481
- hipred
- N
- hipred_score
- 0.190
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.138
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arl14
- Phenotype
Gene ontology
- Biological process
- intracellular protein transport;vesicle-mediated transport
- Cellular component
- cytoplasm;plasma membrane;cytoplasmic vesicle
- Molecular function
- protein binding;GTP binding